目次

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Country share estimation
1.1.3 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 List of Secondary Sources

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Antifungal Drugs Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increasing incidence of fungal infections
3.2.2 Rising R & D pertaining to the development of novel drugs
3.2.3 Increase in awareness
3.3 Market Restraint Analysis
3.3.1 Increasing resistance to antifungal drugs
3.3.2 Presence of generic competition
3.4 Penetration & Growth Prospect Mapping
3.5 Antifungal Drugs - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s
3.7 Pricing Analysis
3.8 Competitive Landscape
3.9 Pipeline Analysis

Chapter 4 Antifungal Drugs Market Drug Class Estimates & Trend Analysis
4.1 Antifungal Drugs Market: Drug Class Movement Analysis
4.2 Azoles
4.2.1 Azoles market, 2018 - 2030 (USD Million)
4.2.2. Voriconazole (Vfend)
4.2.1.1 Voriconazole (Vfend) market, 2018 - 2030 (USD Million)
4.2.3 Posaconazole (Noxafil)
4.2.3.1 Posaconazole (Noxafil) market, 2018 - 2030 (USD Million)
4.2.4 Posaconazole (Noxafil)
4.2.4.1 Clotrimazole (Canesten) market, 2018 - 2030 (USD Million)
4.2.5 Isavuconazole (CRESEMBA)
4.2.5.1 Isavuconazole (CRESEMBA) market, 2018 - 2030 (USD Million)
4.2.6 Isavuconazole (CRESEMBA)
4.2.6.1 Others market, 2018 - 2030 (USD Million)
4.3 Echinocandins
4.3.1 Echinocandins market, 2018 - 2030 (USD Million)
4.3.2 Caspofungin (Cancidas)
4.3.2.1 Caspofungin (Cancidas) market, 2018 - 2030 (USD Million)
4.3.3 Micafungin (Mycamine/ Funguard)
4.3.3.1 Micafungin (Mycamine/ Funguard) market, 2018 - 2030 (USD Million)
4.3.4 Others
4.3.4.1 Others market, 2018 - 2030 (USD Million)
4.4 Polyenes
4.4.1 Polyenes market, 2018 - 2030 (USD Million)
4.4.2 Amphotericin (AmBisome)
4.4.2.1 Amphotericin (AmBisome) market, 2018 - 2030 (USD Million)
4.4.3 Others
4.4.3.1 Others market, 2018 - 2030 (USD Million)
4.5 Allylamines
4.5.1 Allylamines market, 2018 - 2030 (USD Million)
4.5.2 Terbinafine (Lamisil)
4.5.2.1 Terbinafine (Lamisil) market, 2018 - 2030 (USD Million)
4.5.3 Others
4.5.3.1 Others market, 2018 - 2030 (USD Million)
4.6 Others
4.6.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Antifungal Drugs Market Indication Estimates & Trend Analysis
5.1 Antifungal Drugs Market: Indication Movement Analysis
5.2 Dermatophytosis
5.2.1 Dermatophytosis market, 2018 - 2030 (USD Million)
5.3 Aspergillosis
5.3.1 Aspergillosis market, 2018 - 2030 (USD Million)
5.4 Candidiasis
5.4.1 Candidiasis market, 2018 - 2030 (USD Million)
5.4.2 Invasive Candidiasis
5.4.2.1 Invasive candidiasis market, 2018 - 2030 (USD Million)
5.4.3 Vulvovaginal Candidiasis (VVC)
5.4.3.1 VVC market, 2018 - 2030 (USD Million)
5.4.4 Mouth/Throat/Esophageal Candidiasis
5.4.4.1 Mouth/throat/esophageal candidiasis market, 2018 - 2030 (USD Million)
5.4.5 Other candida infections
5.4.5.1 Other candidal infections market, 2018 - 2030 (USD Million)
5.5 Others
5.5.1 Others market, 2018 - 2030 (USD Million)

Chapter 6 Antifungal Drugs Market Regional Estimates & Trend Analysis, by Drug Class and Indications
6.1 Antifungal drugs market share by region, 2021 & 2030
6.2 North America
6.2.1 North America antifungal drugs market, 2018 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. antifungal drugs market, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada antifungal drugs market, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe antifungal drugs market, 2018 - 2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. antifungal drugs market, 2018 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany antifungal drugs market, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific antifungal drugs market, 2018 - 2030 (USD Million)
6.4.2 Japan
6.4.2.1 Japan antifungal drugs market, 2018 - 2030 (USD Million)
6.4.3 China
6.4.3.1 China antifungal drugs market, 2018 - 2030 (USD Million)
6.4.4 India
6.4.4.1 India antifungal drugs market, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America antifungal drugs market, 2018 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil antifungal drugs market, 2018 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico antifungal drugs market, 2018 - 2030 (USD Million)
6.6 MEA
6.6.1 MEA antifungal drugs market, 2018 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa antifungal drugs market, 2018 - 2030 (USD Million)

Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 Novartis AG
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Pfizer, Inc.
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Bayer AG
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Sanofi
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.5 Merck & Co., Inc.
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 GlaxoSmithKline plc
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Abbott
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Glenmark
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Enzon Pharmaceuticals, Inc.
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.10 Astellas Pharma, Inc.
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives

List of Tables
Table 1 Azole antifungal drugs market, by type, 2018 - 2030 (USD Million)
Table 2 Echinocandins antifungal drugs market, by type, 2018 - 2030 (USD Million)
Table 3 Polyenes antifungal drugs market, by type, 2018 - 2030 (USD Million)
Table 4 Allylamines antifungal drugs market, by type, 2018 - 2030 (USD Million)
Table 5 North America antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 6 North America antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 7 U.S. antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 8 U.S. antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 9 Canada antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 10 Canada antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 11 Europe antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 12 Europe antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 13 U.K. antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 14 U.K. antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 15 Germany antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 16 Germany antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 17 Asia Pacific antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 18 Asia Pacific antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 19 Japan antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 20 Japan antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 21 China antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 22 China antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 23 India antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 24 India antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 25 Latin America antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 26 Latin America antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 27 Brazil antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 28 Brazil antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 29 Mexico antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 30 Mexico antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 31 MEA antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 32 MEA antifungal drugs market, by indications, 2018 - 2030 (USD Million)
Table 33 South Africa antifungal drugs market, by class, 2018 - 2030 (USD Million)
Table 34 South Africa antifungal drugs market, by indications, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market summary
Fig. 2 Market trends & outlook
Fig. 3 Market segmentation & scope
Fig. 4 Market driver relevance analysis (Current & future impact)
Fig. 5 Market restraint relevance analysis (Current & future impact)
Fig. 6 Penetration & Growth Prospect Mapping
Fig. 7 Antifungal Drugs SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 8 Porter’s Five Forces Analysis
Fig. 9 Antifungal drugs market class outlook key takeaways
Fig. 10 Antifungal drugs market: Drug class movement analysis
Fig. 11 Azoles market, 2018 - 2030 (USD Million)
Fig. 12 Echinocandins market, 2018 - 2030 (USD Million)
Fig. 13 Polyenes market, 2018 - 2030 (USD Million)
Fig. 14 Allylamines market, 2018 - 2030 (USD Million)
Fig. 15 Others market, 2018 - 2030 (USD Million)
Fig. 16 Antifungal drugs market indication outlook key takeaways
Fig. 17 Antifungal drugs market: Indications movement analysis
Fig. 18 Dermatophytosis market, 2018 - 2030 (USD Million)
Fig. 19 Aspergillosis market, 2018 - 2030 (USD Million)
Fig. 20 Candidiasis market, 2018 - 2030 (USD Million)
Fig. 21 Invasive candidiasis market, 2018 - 2030 (USD Million)
Fig. 22 VVC market, 2018 - 2030 (USD Million)
Fig. 23 Mouth/throat/esophageal candidiasis market, 2018 - 2030 (USD Million)
Fig. 24 Other candidal infections market, 2018 - 2030 (USD Million)
Fig. 25 Others market, 2018 - 2030 (USD Million)
Fig. 26 Regional market place: Key takeaways
Fig. 27 Regional outlook, 2021 & 2030
Fig. 28 North America antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 29 U.S. antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 30 Canada antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 31 Europe antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 32 U.K. antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 33 Germany antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 34 Asia Pacific antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 35 Japan antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 36 China antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 37 India antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 38 Latin America antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 39 Brazil antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 40 Mexico antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 41 MEA antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 42 South Africa antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 43 Strategy framework
Fig. 44 Participant categorization